Uric acid and glucose metabolism in uncomplicated Libyan diabetic patients

Abstract :

Uric acid has increasingly been associated with insulin resistance, hyperinsulinemia, and type 2 diabetes mellitus. Diabetic patients who are hyperuricemic have a risk of developing diabetic complications. Pathogenesis of uric acid may decrease nitric oxide bioavailability in vascular smooth muscle, endothelial cells and direct scavenging of nitric oxide by uric acid. A decrease in endothelial nitric oxide production by uric acid has also been associated with endothelial dysfunction and insulin resistance. This study aims is to determine the relationship between uric acid and glucose levels in patients with type 2 diabetes mellitus. The study included 161 Libyan patients (67 males and 94 females) diagnosed with type 2 diabetes mellitus. Both levels of serum uric acid and hemoglobin A1c (HbA1c) were determined. The patients were divided into two groups. The controllable diabetic group with HbA1c of less than 06.0% and the uncontrollable diabetic group with HbA1c of more than 06.0%. Patients who are suffering from type 2 diabetes mellitus without complications were included whereas patients with smoking, alcoholism, nephrotic disease, malignancy, hepatitis, and renal failure or kidney disease were excluded. The mean and standard deviation of uric acid, HbA1c and Pearson correlation coefficient test were considered. In the controllable diabetic group, serum uric acid mean was found to be 4.807 ± 1.39 and HbA1c was found to be 5.032 ± 1.39. In the uncontrollable diabetic group, serum uric acid was 4.897 ± 1.66 and HbA1c was 8.396 ± 1.65. Uric acid level has significantly been correlated with HBA1C in controlled and uncontrolled diabetic patients (p < 0.05). In addition, the uric acid level was found to be higher in uncontrolled diabetic group than that in the controlled group (p < 0.05). A possible relationship between serum uric acid and incidence of type 2 diabetes mellitus was noted. Thus, uric acid can be used as a potential biomarker to indicate impaired glucose metabolism.


References

1. Suryawanshi KS, Jagtap S, Belwalker GJ, Dhonde SP, Nagane NS, Joshi VS (2015) To study serum uric acid and urine microalbumin in type-2 diabetes mellitus. International Journal of Medical Science. 2 (3): 24-29.
2. Adam IK, Sheye FA, Magami SM, Yusuf MB (2012) Uric acid profile in apparently healthy people and diabetics. European Journal of Chemistry. 3 (1): 10-12. doi.org/10.5155/eurjchem.3.10-12.506
3. Gill A, Kukreja S, Malhotra N, Chhabra N (2013) Correlation of the serum insulin and the serum uric acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research. 7 (7): 1295-1297. doi: 10.7860/JCDR/2013/6017.3121
4. Facchini F, Chen YD, Hollenbeck CB, Reavan GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 266 (21): 3008-3011. doi:10.1001/jama.1991.03470210076036
5. Galvan AQ, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E (1995) Effect of insulin on uric acid excretion in humans. American Journal of Physiology-Endocrinology and Metabolism. 268 (1): E1-E5. doi: 10.1152/ajpendo.1995.268.1.E1
6. Heinig M, Johnson RJ (2006) Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleveland Clinic Journal of Medicine. 73 (12): 1059-1064. doi: 10.3949/ccjm.73.12.1059
7. Yamanaka H (2011) Gout and hyperuricemia in young people. Current Opinion in Rheumatology. 23 (2): 156-160. doi: 10.1097/BOR.0b013e3283432d35
8. Muscelli E, Natali A, Bianchi S, Bigazzi R, Galvan AQ, Sironi AM, Frascerra S, Ciociaro D, Ferrannini (1996) Effect of insulin on renal sodium and uric acid handling in essential hypertension. American Journal of Hypertension. 9 (8): 746-752. doi: 10.1016/0895-7061(96)00098-2
9. Tsunoda S, Kamide K, Minami J, Kawano Y (2002) Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. American Journal of Hypertension. 15 (8): 697-701. doi: 10.1016/s0895-7061(02)02953-9
10. Hayden MR, Tyagi SC (2004) Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutrition and Metabolism. 1 (1): 10. doi: 10.1186/1743-7075-1-10
11. Reaven GM (1997) The kidney: an unwilling accomplice in syndrome X. American Journal of Kidney Diseases. 30 (6): 928-931. doi: 10.1016/s0272-6386(97)90106-2
12. Hidayat MF, Syafril S, Lindarto D (2015) Elevated uric acid level decreases glycated hemoglobin in type 2 diabetes mellitus. Universa Medicina. 33 (3): 199-204. https://doi: 10.18051/UNIVMED.2014.V33.199-204
13. Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey. Rheumatology. 47 (5): 713-717. doi: 10.1093/rheumatology/ken066
14. Madianov IV, Balabolkin MI, Markov DS, Markova TN (1999) Main causes of hyperuricemia in diabetes mellitus. Terapevticheskii arkhiv. 72 (2): 55-58. PMID: 10717929

Citation :

Shateila et al. (2023) Uric acid and glucose metabolism in uncomplicated Libyan diabetic patients. Mediterr J Pharm Pharm Sci. 3 (3): 27-30. https://doi.org/10.5281/zenodo.8327189